The FDA granted de novo approval to Neuromod Devices' Lenire, a bimodal neuromodulation device that is the first of its kind to be approved to treat tinnitus, the company announced. The device ...

91.5% of patients experienced clinically meaningful reductions in tinnitus after 12 weeks of treatment with Lenire. 220 patients were analyzed, making the paper one of the largest real-world analyses ...

Lenire is now Tinnitus UK's safest and most effective available tinnitus treatment option following a wholesale review of the charity's rating system. Tinnitus UK's new rating acknowledges Lenire's ...

Tinnitus is when you hear a persistent ringing or another sound in your ear that is not caused by an outside source. Some of the potential causes are hearing loss, an ear canal blockage, and certain ...

When Elliot Gerberg wakes up, he often hears a single tone in his head. The tone — a ceaseless, monotone ringing in his ears that Gerberg finds exhausting — is a sign of tinnitus, a condition without ...

Tinnitus, the constant perception of sound without an external source, affects 15% of adults in the United States. For many, it’s an occasional nuisance, but for approximately 40% of sufferers, it ...

Tinnitus, the sensation of hearing sound without an external source, can affect nearly half of people in some studies. This phantom noise often takes a toll on sleep, focus, and mental health, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo approval to Neuromod Devices’ Lenire, a noninvasive device for the treatment of ...

The first real-world analysis of tinnitus patients treated with Lenire in the United States has been submitted to a journal for peer-review and is now available on an online pre-print server for ...

CHICAGO, Aug. 20, 2024 /PRNewswire/ -- Nature Communications has published the peer-reviewed results of Neuromod Devices' TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) ...

The "Tinnitus Market - A Global and Regional Analysis: Focus on Route of Administration, Type, Drug Class, Distribution Channel, Country, and Region - Analysis and Forecast, 2025-2035" report has been ...